News

Pharmabiz51m
HotSpot presents preclinical data from small molecule CBM signalosome inhibitor programme at ESMO Gastrointestinal Cancers Congress 2025
In combination with a KRAS inhibitor, HotSpot’s CBM signalosome inhibitor achieved complete suppression of downstream signalling in KRASG12X cell lines. HotSpot’s CBM signalosome inhibitor ...
Pharmabiz1h
Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System
Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...
Pharmabiz2h
Onco-Innovations inks agreement with Nucro-Technics for IND-enabling studies
Onco-Innovations inks agreement with Nucro-Technics for IND-enabling studies: Vancouver, Canada Tuesday, July 8, 2025, 10:00 Hrs [IST] Onco-Innovations Limited, a Canadian-based c ...
Pharmabiz3h
Chugai Pharma and Gero sign joint research and license agreement to develop novel therapies for age-related diseases
Chugai Pharma and Gero sign joint research and license agreement to develop novel therapies for age-related diseases: Tokyo Tuesday, July 8, 2025, 09:00 Hrs [IST] Chugai Pharmaceu ...
Pharmabiz4h
DoC reviews, discusses key issues with stakeholders in exports, imports, trade data and regulations
DoC reviews, discusses key issues with stakeholders in exports, imports, trade data and regulations: Shardul Nautiyal, Mumbai Tuesday, July 8, 2025, 08:00 Hrs [IST] In order to ad ...
Pharmabiz4h
NPPA notifies retail prices of 71 formulations
The National Pharmaceutical Pricing Authority (NPPA) has notified the retail prices of 71 formulations as per the provisions to set prices of new drugs under the Drugs Prices Control Order (DPCO), ...
Pharmabiz4h
NPPA notifies separate retail price of GSK's cold medicine
The National Pharmaceutical Pricing Authority (NPPA) has notified the separate retail price of GlaxoSmithKline (GSK) Asia's cold medicine combination paracetamol 500 mg and phenylephrine HCl 10 mg at ...
Pharmabiz4h
India and Uzbekistan eye strategic pharma collaboration to strengthen bilateral trade
India and Uzbekistan eye strategic pharma collaboration to strengthen bilateral trade: Shardul Nautiyal, Mumbai Tuesday, July 8, 2025, 08:00 Hrs [IST] In a significant move toward ...
Pharmabiz4h
FOPE president asks MSMEs to implement revised Schedule M as govt unlikely to extend deadline
FOPE president asks MSMEs to implement revised Schedule M as govt unlikely to extend deadline: Peethaambaran Kunnathoor, Chennai Tuesday, July 8, 2025, 08:00 Hrs [IST] The preside ...
Pharmabiz18h
Akeso enrols first patient in phase Ia trial for AK146D1, a bispecific ADC targeting Trop2 and Nectin4
Akeso enrols first patient in phase Ia trial for AK146D1, a bispecific ADC targeting Trop2 and Nectin4: Hong Kong Monday, July 7, 2025, 18:00 Hrs [IST] Akeso, Inc., a leading biop ...
Pharmabiz21h
InnoCare receives China NMPA approval to conduct clinical trial of a novel B7-H3 targeted ADC ICP-B794
InnoCare receives China NMPA approval to conduct clinical trial of a novel B7-H3 targeted ADC ICP-B794: Beijing Monday, July 7, 2025, 15:00 Hrs [IST] InnoCare Pharma, a leading bi ...
Pharmabiz22h
Nxera Pharma to get US$ 4.8 mn in milestone payments following Centessa’s initiation of clinical development of ORX142
Nxera Pharma to get US$ 4.8 mn in milestone payments following Centessa’s initiation of clinical development of ORX142: Tokyo, Japan Monday, July 7, 2025, 14:00 Hrs [IST] Nxera ...